High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies-Reference-Cited by-同舟云学术

High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies

Published:2016-03-16 Issue:5 Volume:21 Page:272-279
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Samuelson Clare¹,O'Toole Laurence²,Boland Elaine³,Greenfield Diana⁴,Ezaydi Yousef¹,Ahmedzai Sam H.³,Snowden John A.¹

Affiliation:

1. Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, UK

2. Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, UK

3. Academic Unit of Supportive Care, University of Sheffield, UK

4. Department of Oncology, Sheffield Teaching Hospitals NHS Foundation Trust, UK

Funder

Myeloma UK

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://tandfonline.com/doi/pdf/10.1080/10245332.2015.1122258

Reference43 articles.

1. Guidelines for the diagnosis and management of multiple myeloma 2011

2. Guidelines for supportive care in multiple myeloma 2011

3. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?

4. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

5. Living With Advanced But Stable Multiple Myeloma: A Study of the Symptom Burden and Cumulative Effects of Disease and Intensive (Hematopoietic Stem Cell Transplant-Based) Treatment on Health-Related Quality of Life

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward platelet transcriptomics in cancer diagnosis, prognosis and therapy;British Journal of Cancer;2021-11-22

2. How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review;Quality of Life Research;2019-12-17

3. The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation;Annals of Noninvasive Electrocardiology;2018-01-24

4. Pulmonary Toxicities of Anticancer Treatment;The MASCC Textbook of Cancer Supportive Care and Survivorship;2018

5. Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study;Clinical Lymphoma Myeloma and Leukemia;2017-02